GlucoTrack Statistics
Total Valuation
GlucoTrack has a market cap or net worth of $2.25 million. The enterprise value is $1.91 million.
| Market Cap | 2.25M |
| Enterprise Value | 1.91M |
Important Dates
The next estimated earnings date is Thursday, August 13, 2026, after market close.
| Earnings Date | Aug 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
GlucoTrack has 6.26 million shares outstanding. The number of shares has increased by 2,011.78% in one year.
| Current Share Class | 6.26M |
| Shares Outstanding | 6.26M |
| Shares Change (YoY) | +2,011.78% |
| Shares Change (QoQ) | +79.45% |
| Owned by Insiders (%) | 0.20% |
| Owned by Institutions (%) | 4.19% |
| Float | 6.20M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.85
| Current Ratio | 0.85 |
| Quick Ratio | 0.79 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -178.67 |
Financial Efficiency
Return on equity (ROE) is -527.20% and return on invested capital (ROIC) is -204.68%.
| Return on Equity (ROE) | -527.20% |
| Return on Assets (ROA) | -150.30% |
| Return on Invested Capital (ROIC) | -204.68% |
| Return on Capital Employed (ROCE) | 2,713.25% |
| Weighted Average Cost of Capital (WACC) | 4.53% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.13M |
| Employee Count | 15 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -94.56% in the last 52 weeks. The beta is 0.76, so GlucoTrack's price volatility has been lower than the market average.
| Beta (5Y) | 0.76 |
| 52-Week Price Change | -94.56% |
| 50-Day Moving Average | 0.56 |
| 200-Day Moving Average | 3.03 |
| Relative Strength Index (RSI) | 38.95 |
| Average Volume (20 Days) | 1,329,596 |
Short Selling Information
The latest short interest is 501,768, so 8.02% of the outstanding shares have been sold short.
| Short Interest | 501,768 |
| Short Previous Month | 363,693 |
| Short % of Shares Out | 8.02% |
| Short % of Float | 8.09% |
| Short Ratio (days to cover) | 0.46 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -16.80M |
| Pretax Income | -16.89M |
| Net Income | -16.89M |
| EBITDA | -16.74M |
| EBIT | -16.80M |
| Earnings Per Share (EPS) | -$17.09 |
Balance Sheet
The company has $3.93 million in cash and $3.59 million in debt, with a net cash position of $341,000 or $0.05 per share.
| Cash & Cash Equivalents | 3.93M |
| Total Debt | 3.59M |
| Net Cash | 341,000 |
| Net Cash Per Share | $0.05 |
| Equity (Book Value) | -851,000 |
| Book Value Per Share | -0.34 |
| Working Capital | -761,000 |
Cash Flow
In the last 12 months, operating cash flow was -$16.35 million and capital expenditures -$87,000, giving a free cash flow of -$16.44 million.
| Operating Cash Flow | -16.35M |
| Capital Expenditures | -87,000 |
| Depreciation & Amortization | 56,000 |
| Net Borrowing | 3.59M |
| Free Cash Flow | -16.44M |
| FCF Per Share | -$2.63 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
GlucoTrack does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2,011.78% |
| Shareholder Yield | -2,011.78% |
| Earnings Yield | -749.51% |
| FCF Yield | -729.41% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on June 16, 2025. It was a reverse split with a ratio of 1:60.
| Last Split Date | Jun 16, 2025 |
| Split Type | Reverse |
| Split Ratio | 1:60 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |